Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 4/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30238714 | 0.82 | SMN1; SMN2 (0.34) | CHRNA7 | |
| SCHEMBL16169022 | 0.82 | PDE2A (0.38) | CA1CA2 | |
| SCHEMBL16168999 | 0.82 | NPSR1 (0.39) | CA1CA2 | |
| SCHEMBL29907881 | 0.80 | NR1H4 (0.43) | CA1CA2 | |
| SCHEMBL23782649 | 0.80 | NR1H4 (0.43) | CA1CA2 | |
| SCHEMBL23782647 | 0.80 | NR1H4 (0.43) | CA1CA2 | |
| SCHEMBL23782648 | 0.80 | NR1H4 (0.43) | CA1CA2 | |
| SCHEMBL2276240 | 0.79 | S1PR1 (0.36) | — | |
| SCHEMBL16169025 | 0.78 | CHRNA1 (0.33) | — | |
| SCHEMBL23782636 | 0.77 | CA1 (0.40) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230131180-A1 | Processes for producing amide compounds, and their crystalline and salt form | ALPHALA CO., LTD. (TW) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230131180-A1 | Processes for producing amide compounds, and their crystalline and salt form | ACMSD, REN, H1-4 | KEAP1 4189/4885NFE2L2 1574/4885CHRNA7 4245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.